Search
Monday 6 April 2015
  • :
  • :

Productive Stocks To Watch List: Kornit Digital, (NASDAQ:KRNT), Nymox Pharmaceutical, (NYMX), TCP International Holdings (TCPI), CAMAC Energy, (CAK)

On Thursday, Kornit Digital, Ltd. (NASDAQ:KRNT)’s shares skyrocketed 40%, and closed at $14, hitting new 52-week high of $14.67.

Last Wednesday, Kornit Digital Ltd., declared the pricing of its initial public offering of 7,100,000 ordinary shares at a price to the public of $10.00 per share. All of the shares are being offered by Kornit. In addition, Kornit has granted the underwriters a 30-day option to purchase up to an additional 1,065,000 ordinary shares to cover over-allotments, if any. The shares started trading on the NASDAQ Global Market on April 2, 2015 under the ticker symbol “KRNT.”

On the other hand, Nymox Pharmaceutical Corporation (NYMX), is undertaking further analyses of its pivotal U.S. Phase 3 studies of NX-1207 for prostate enlargement (BPH). This will comprise new long-term data from Studies NX02-0017 and NX02-0018. The Corporation anticipates to provide these new pivotal Phase 3 study results in Q2 or early Q3 this year.

The pivotal U.S. studies NX02-0017 and NX02-0018 were initiated in 2009. Enrollment of NX02-0017 (499 patients randomized) was accomplished in 2012; enrollment of NX02-0018 (498 patients randomized) was accomplished in 2013. 973 patients were injected with either NX-1207 2.5 mg (n=582) or saline vehicle alone as control (n=391). At 12 months post-treatment there was no overall top-line statistical significance for the efficacy of treatment in terms of BPH Symptom Score improvement vs controls. The safety profile of NX-1207 was excellent.

Nymox Pharmaceutical Corporation (NASDAQ:NYMX)’s shares jumped nearly 37.63%, settled at $1.73.

Kornit develops, designs and markets innovative digital printing solutions for the global printed textile industry. Kornit’s solution comprises its proprietary digital printing systems, ink and other consumables, associated software and value added services.

Nymox Pharmaceutical Corporation, a biopharmaceutical corporation, is engaged in the research and development of products for the aging population. It provides NicAlert and TobacAlert products that use urine or saliva to detect use of and exposure to tobacco products, in addition to AlzheimAlert, a proprietary urine assay that aid physicians in the diagnosis of Alzheimer’s disease.

TCP International Holdings Ltd. (NYSE:TCPI), with shares climbed 23.50%, and closed at $2.26.

TCP International’s product validation review is proceeding as predictable. The Corporation has accomplished testing on substantially all of its fastest moving SKUs. For the remaining SKUs, TCP anticipates to complete validation shortly. In addition, the Corporation affirmed that UL certified designs are accessible for all products and that products being shipped are UL certified.

TCP issued the following statement:

“The TCP team would like to thank TCP customers for the outspoken support and patience they have extended to us during this period. The support we have received from our customers – both new and existing, large and small – is a testament to TCP’s products and talented team of more than 7,000 employees worldwide. Our customers can count on us to continue providing the superior service and quality, innovative lighting technology for which TCP has long been known.”

TCP International Holdings Ltd., together with its auxiliaries, designs, develops, manufactures, and markets lighting products and accessories to the commercial, industrial, and retail markets worldwide.

CAMAC Energy, Inc. (NYSEMKT:CAK), gained 20.80%, and closed at $0.65.

Last Tuesday, CAMAC Energy, Inc., has finished completion operations on the Oyo-8 well, located offshore Nigeria, and is now ready to commence oil production.

Oyo-8 is hooked up to the FPSO Armada Perdana owned by Bumi Armada Berhad. However, CAMAC has been informed by Bumi that the FPSO is not ready to receive oil production from the well due to class certification inspections of the vessel’s mooring lines being conducted by the American Bureau of Shipping. Bumi estimates these inspections to be accomplished within two weeks, at which time Oyo-8 will be allowed to produce into the FPSO.

In the meantime, CAMAC is demobilizing the Sedco Express drilling rig from the Oyo-8 location and the rig will then mobilize to the Oyo-6 well location to continue its planned Oyo field operations. The Corporation does not anticipate further changes to the project plan of the Oyo-7 well as a result of the FPSO inspection delays.

CAMAC Energy is an independent oil and gas exploration and production corporation focused on energy resources in sub-Saharan Africa. Its asset portfolio comprises of nine licenses across four countries covering an area of 10 million net acres, counting current production and other exploration projects offshore Nigeria, in addition to exploration licenses offshore Ghana, Kenya, and Gambia, and onshore Kenya.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *